These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34458738)

  • 21. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use.
    Reubi JC; Schär JC; Waser B; Wenger S; Heppeler A; Schmitt JS; Mäcke HR
    Eur J Nucl Med; 2000 Mar; 27(3):273-82. PubMed ID: 10774879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue.
    Ni R; Gillberg PG; Bergfors A; Marutle A; Nordberg A
    Brain; 2013 Jul; 136(Pt 7):2217-27. PubMed ID: 23757761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Somatostatin SST
    Nemes B; Bölcskei K; Kecskés A; Kormos V; Gaszner B; Aczél T; Hegedüs D; Pintér E; Helyes Z; Sándor Z
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models.
    Scheich B; Gaszner B; Kormos V; László K; Ádori C; Borbély É; Hajna Z; Tékus V; Bölcskei K; Ábrahám I; Pintér E; Szolcsányi J; Helyes Z
    Neuropharmacology; 2016 Feb; 101():204-15. PubMed ID: 26387439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel agonists of benzodiazepine receptors: design, synthesis, binding assay and pharmacological evaluation of 1,2,4-triazolo[1,5-a]pyrimidinone and 3-amino-1,2,4-triazole derivatives.
    Faizi M; Dabirian S; Tajali H; Ahmadi F; Zavareh ER; Shahhosseini S; Tabatabai SA
    Bioorg Med Chem; 2015 Feb; 23(3):480-7. PubMed ID: 25564376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding properties of somatostatin receptor subtypes.
    Bruns C; Raulf F; Hoyer D; Schloos J; Lübbert H; Weckbecker G
    Metabolism; 1996 Aug; 45(8 Suppl 1):17-20. PubMed ID: 8769372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
    Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
    J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the somatostatin receptor subtype 4 selective agonist J-2156 on sensory neuropeptide release and inflammatory reactions in rodents.
    Helyes Z; Pintér E; Németh J; Sándor K; Elekes K; Szabó A; Pozsgai G; Keszthelyi D; Kereskai L; Engström M; Wurster S; Szolcsányi J
    Br J Pharmacol; 2006 Oct; 149(4):405-15. PubMed ID: 16953190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatostatin receptors mediating inhibition of basal and stimulated electrogenic ion transport in rat isolated distal colonic mucosa.
    McKeen ES; Feniuk W; Humphrey PP
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):402-11. PubMed ID: 8532068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New sst4/5-selective somatostatin peptidomimetics based on a constrained tryptophan scaffold.
    Feytens D; Cescato R; Reubi JC; Tourwé D
    J Med Chem; 2007 Jul; 50(14):3397-401. PubMed ID: 17559206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents.
    Prasad V; Birzin ET; McVaugh CT; Van Rijn RD; Rohrer SP; Chicchi G; Underwood DJ; Thornton ER; Smith AB; Hirschmann R
    J Med Chem; 2003 May; 46(10):1858-69. PubMed ID: 12723949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatostatin activates two types of inwardly rectifying K+ channels in MIN-6 cells.
    Smith PA; Sellers LA; Humphrey PP
    J Physiol; 2001 Apr; 532(Pt 1):127-42. PubMed ID: 11283230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a new class of selective nonsteroidal progesterone receptor agonists.
    Dong Y; Roberge JY; Wang Z; Wang X; Tamasi J; Dell V; Golla R; Corte JR; Liu Y; Fang T; Anthony MN; Schnur DM; Agler ML; Dickson JK; Lawrence RM; Prack MM; Seethala R; Feyen JH
    Steroids; 2004 Mar; 69(3):201-17. PubMed ID: 15072922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Di- and trisubstituted pyrazolo[1,5-a]pyridine derivatives: synthesis, dopamine receptor binding and ligand efficacy.
    Löber S; Aboul-Fadl T; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 2002 Feb; 12(4):633-6. PubMed ID: 11844688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An in-silico approach: identification of PPAR-γ agonists from seaweeds for the management of Alzheimer's Disease.
    Kotha S; B S; Kulkarni VM; S RS; B HK; R H
    J Biomol Struct Dyn; 2021 Apr; 39(6):2210-2229. PubMed ID: 32216605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.